Ikarian Capital’s BioVie BIVI Stock Holding History

Ikarian Capital’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,573	Closed	-$1.56M	–	145
2023 Q3	$1.56M	Buy	4,573 +87	+2%	+$34K	0.19%	85
2023 Q2	$1.93M	Buy	4,486 +1,000	+29%	+$674K	0.31%	66
2023 Q1	$2.82M	Buy	+3,486	New	+$2.31M	0.64%	48

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ikarian Capital's BIVI Position: Q4 2023 in Review

Ikarian Capital sold out of BioVie (BIVI) in Q4 2023, closing a stake of 4,573 shares — an estimated $1.56M sold.

Ikarian Capital first reported a position in BIVI in Q1 2023 and held it in 3 quarters. The position peaked at $2.82M in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q4 2023.

Ikarian Capital reported no remaining BioVie position as of Q4 2023 after selling out during the quarter.
Ikarian Capital sold 4,573 BioVie shares in Q4 2023, an estimated $1.56M.
Ikarian Capital first reported a position in BioVie in Q1 2023 and held it in 3 quarters.
Ikarian Capital's BioVie position peaked at $2.82M in Q1 2023.
53 funds tracked by Wall St. Rank held BioVie as of Q4 2023.

Based on Ikarian Capital's 13F filing for Q4 2023, filed 14 Feb 2024.